QbD

Designing Quality into Biomanufacturing

Miguel Carrion; Michelle Kneeland

Tanvex CDMO

Clinical Trials

Passion and Understanding Essential for Rare Disease Clinical Trials

Juliet Moritz

Ergomed

Fill/Finish

Superior Performance of SaniSure® Pharm-A-Clear LH® Tubing in Extended Fill/Finish Applications

Alex Van Hagen, Ph.D.; Nicholas Brust

Sanisure

Oncology Trials

Navigating the Complex Landscape of Oncology Trials

Colin Hayward, MB BS

Ergomed

Lyophilization

Pioneering Innovation in Pharmaceutical Lyophilization

Thermo Fisher Scientific

Financing

Why Life Science Companies Surged amid a Global M&A Downturn

Amanda Wang

That's Nice LLC

CDMO

Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO

Janet Hoogstraate, Ph.D.

NorthX Biologics

AI

Plan Ahead: Mastering Your AI Budget for 2025 Success

Stephen Tharp

Dotmatics

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang

Samsung Biologics

Bioassays

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Anke Hartung, Ph.D.,

Tanvex CDMO

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Tom Adie, Ph.D.; Elena Stoyanova, Ph.D.

Touchlight

Biopharma

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Gardiner Smith; Reiner Gentz, Ph.D.

Fab Biopharma

Process Development

Economic Benefits of Digital Process Development

Fabian Feidl, Ph.D.

DataHow

Biotech

Five Small Biotechs to Watch: October 2024

David Alvaro, Ph.D.

Pharma's Almanac

Commercialization

Development Strategies for Overcoming Commercialization Challenges

Matthias Lucke, Ph.D.

Coriolis Pharma

Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.

PPD, part of Thermo Fisher Scientific

Biosimilars

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Natalia Bourguignon, Ph.D.; Joandiet Castaneda; Andrew Majdoch, M.Sc.

GBI

Female-Centric

Transforming Drug Development through a Female Perspective

Chia Chia Sun; William Freimuth, Ph.D., M.D.

Fab Biopharma

Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

Minitablets

Minitablets: Enhancing Safety and Palatability for Pediatric Medicines

Gus LaBella

Mikart